Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1229577

Cover Image

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1229577

Metered Dose Inhalers Market (Product Type: Manual Actuated pMDIs and Breath Actuated pMDIs; Disease Indication: Asthma, COPD, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

PUBLISHED:
PAGES: 216 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5795
PDF (Multi-user License)
USD 8795
PDF (Corporate License)
USD 11795

Add to Cart

The report provides revenue of the global metered dose inhalers market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global metered dose inhalers market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the metered dose inhalers market.

The report delves into the competitive landscape of the global metered dose inhalers market. Key players operating in the global metered dose inhalers market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global metered dose inhalers market profiled in this report.

Product Code: TMRGL32174

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Metered Dose Inhalers Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Metered Dose Inhalers Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Forces Analysis

5. Key Insights

  • 5.1. Respiratory Disease Epidemiology
  • 5.2. Technological Advancements
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Metered Dose Inhalers Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Manual Actuated pMDIs
    • 6.3.2. Breath Actuated pMDIs
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Metered Dose Inhalers Market Analysis and Forecast, by Disease Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 7.3.1. Asthma
    • 7.3.2. COPD
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Disease Indication

8. Global Metered Dose Inhalers Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Metered Dose Inhalers Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Metered Dose Inhalers Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2017-2031
    • 10.2.1. Manual Actuated pMDIs
    • 10.2.2. Breath Actuated pMDIs
  • 10.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 10.3.1. Asthma
    • 10.3.2. COPD
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Disease Indication
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Metered Dose Inhalers Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Manual Actuated pMDIs
    • 11.2.2. Breath Actuated pMDIs
  • 11.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 11.3.1. Asthma
    • 11.3.2. COPD
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Disease Indication
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Metered Dose Inhalers Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Manual Actuated pMDIs
    • 12.2.2. Breath Actuated pMDIs
  • 12.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 12.3.1. Asthma
    • 12.3.2. COPD
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Disease Indication
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Metered Dose Inhalers Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Manual Actuated pMDIs
    • 13.2.2. Breath Actuated pMDIs
  • 13.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 13.3.1. Asthma
    • 13.3.2. COPD
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Disease Indication
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Metered Dose Inhalers Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. Manual Actuated pMDIs
    • 14.2.2. Breath Actuated pMDIs
  • 14.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 14.3.1. Asthma
    • 14.3.2. COPD
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Disease Indication
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company (2021)
  • 15.3. Company Profiles
    • 15.3.1. AstraZeneca
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Type Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Cipla Limited
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Type Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Novartis AG
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Type Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Merck & Co., Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Type Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Sanofi
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Type Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
    • 15.3.6. Boehringer Ingelheim
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Type Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
    • 15.3.7. Teva Pharmaceutical Industries Ltd.
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Type Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
    • 15.3.8. Mylan N.V.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Type Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
    • 15.3.9. Hikma Pharmaceuticals plc
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Type Portfolio
      • 15.3.9.3. Financial Overview
    • 15.3.10. GlaxoSmithKline
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Type Portfolio
      • 15.3.10.3. Financial Overview
Product Code: TMRGL32174

List of Tables

  • Table 01: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 03: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 04: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 07: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 08: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 09: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 11: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 12: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 16: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 17: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 19: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 20: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 21: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 23: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017-2031
  • Table 24: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Metered Dose Inhalers Market Value Share, by Product Type, 2021
  • Figure 03: Global Metered Dose Inhalers Market Value Share, by Distribution Channel, 2021
  • Figure 04: Global Metered Dose Inhalers Market Value Share, by Disease Indication, 2021
  • Figure 05: Global Metered Dose Inhalers Market Value Share, by Region, 2021
  • Figure 06: Global Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 07: Global Metered Dose Inhalers Market Value (US$ Mn), by Manual Actuated pMDIs, 2017-2031
  • Figure 08: Global Metered Dose Inhalers Market Value (US$ Mn), by Breath Actuated pMDIs, 2017-2031
  • Figure 09: Global Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 10: Global Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 11: Global Metered Dose Inhalers Market Value (US$ Mn), by Asthma, 2017-2031
  • Figure 12: Global Metered Dose Inhalers Market Value (US$ Mn), by COPD, 2017-2031
  • Figure 13: Global Metered Dose Inhalers Market Value (US$ Mn), by Others, 2017-2031
  • Figure 14: Global Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 15: Global Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 16: Global Metered Dose Inhalers Market Value (US$ Mn), by Hospital Pharmacies, 2017-2031
  • Figure 17: Global Metered Dose Inhalers Market Value (US$ Mn), by Retail Pharmacies, 2017-2031
  • Figure 18: Global Metered Dose Inhalers Market Value (US$ Mn), by Online Pharmacies, 2017-2031
  • Figure 19: Global Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 20: Global Metered Dose Inhalers Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 21: Global Metered Dose Inhalers Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 22: North America Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 23: North America Metered Dose Inhalers Market Value Share (%), by Country, 2021 and 2031
  • Figure 24: North America Metered Dose Inhalers Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 25: North America Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 26: North America Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 27: North America Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 28: North America Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 29: North America Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 30: North America Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 31: Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 32: Europe Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 33: Europe Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 34: Europe Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 35: Europe Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 36: Europe Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 37: Europe Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 38: Europe Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 39: Europe Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 40: Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 41: Asia Pacific Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 42: Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 43: Asia Pacific Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 44: Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 45: Asia Pacific Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 46: Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 47: Asia Pacific Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 48: Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 49: Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 50: Latin America Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 51: Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 52: Latin America Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 53: Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 54: Latin America Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 55: Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 56: Latin America Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 57: Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 58: Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 59: Middle East & Africa Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 60: Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 61: Middle East & Africa Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 62: Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 63: Middle East & Africa Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 64: Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022-2031
  • Figure 65: Middle East & Africa Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 66: Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 67: Global Metered Dose Inhalers Market Share Analysis, by Company, 2021
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!